Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9
Authors:
- 5 March 2014
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 44 (5) , 1551-1560
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 45 references indexed in Scilit:
- Host–tumor interactions in nasopharyngeal carcinomasSeminars in Cancer Biology, 2012
- Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patientsWorld Journal of Surgical Oncology, 2011
- Blockade of interleukin‐6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myelomaBritish Journal of Haematology, 2011
- A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancerBritish Journal of Cancer, 2010
- Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinomaBMC Cancer, 2010
- Interleukin-6 in bone metastasis and cancer progressionEuropean Journal of Cancer, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Targeted inhibition of interleukin‐6 with CNTO 328 sensitizes pre‐clinical models of multiple myeloma to dexamethasone‐mediated cell deathBritish Journal of Haematology, 2009
- IL-6 involvement in epithelial cancersJournal of Clinical Investigation, 2007
- Inflammation and cancerNature, 2002